Medifast, Inc.
MED
$10.53
$0.100.96%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -2,362.05% | -300.62% | 130.42% | -109.28% | -86.73% |
| Total Depreciation and Amortization | 8.79% | 8.08% | 31.89% | 0.58% | -5.01% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 485.78% | -48.06% | -95.17% | 247.46% | -138.98% |
| Change in Net Operating Assets | -28.69% | 670.83% | -1,001.53% | 65.09% | 47.42% |
| Cash from Operations | -6.69% | 33.52% | -125.85% | -53.23% | -147.02% |
| Capital Expenditure | 40.88% | 1.94% | 28.90% | 17.33% | -141.54% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 79.01% | -3,195.41% | 2,580.64% | 43.04% | -75.23% |
| Cash from Investing | 74.53% | -701.40% | 627.53% | 25.98% | -81.07% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -100.00% |
| Repurchase of Common Stock | -- | 100.00% | 93.75% | 54.83% | 90.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | 100.00% | 75.00% | 72.68% | 100.00% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 200.00% | 100.00% | 90.00% | 62.24% | 99.99% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | 100.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 58.07% | -129.74% | -5.39% | -73.97% | -33.14% |